VIVIAN ROSA: Open Payments
NPI 1245781624 · ATLANTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 37 payments from 8 companies in 2025. Trend: 2023 $808 · 2024 $1,138 · 2025 $866
Food & beverage: $710Education: $156
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $330 |
| Janssen Biotech, Inc. | 4 | $136 |
| Madrigal Pharmaceuticals | 4 | $122 |
| GENZYME CORPORATION | 3 | $95 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Ardelyx, Inc. | 1 | $33 |
| PFIZER INC. | 2 | $28 |
Products named: SKYRIZI, TREMFYA, REZDIFFRA, DUPIXENT, CREON, LINZESS, XIFAXAN, ENTYVIO.
Industry payments across FL — which companies pay providers there.
